An article titled ‘Integrating Nanotechnology into the Life Sciences: Lessons Learned’ will appear in the International Journal of Pharmaceutical Sciences and Nanotechnology.
The article was written by RJ Lee Group’s scientists, Dr. Linxian Wu, Ms. Julianne Wolfe and Dr. Kristin L. Bunker. At RJ Lee Group, Wu serves as the Director of Biotechnology and Pharmaceutical Services, Wolfe works as the Manager of Biotechnology and Pharmaceutical Services, while Bunker is a senior scientist.
The article will be featured in Volume 5, Issue 1 of the journal, which is circulated globally every quarter and covers issues associated with pharmaceutical sciences. The article features specific illustrations of nanotechnology applications in the life science industry, describing issues in the integration of nanotechnology in detail and suitable solutions for those issues. It analyzes major problems related to the integration of nanotechnology as it is useful in pharmaceutical standardization, sample preparation and analysis, quality control, and safety considerations.
The article concludes that one specific issue is the non availability of standardization in the nanotechnology community. It also emphasizes that such standards must be established by the scientific community.
RJ Lee Group, an industrial forensics laboratory, offers advanced solutions to challenges in information management, forensic engineering, and materials characterization. The laboratory provides support strategies and solutions to customers utilizing its scientific expertise, technology and instrumentation.